SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company s first fertility control product, ContraPest , is marketed for use in controlling rat infestations. ContraPest s novel technology and approach targets the reproductive capabilities of both sexes, inducing egg loss in female rodents and impairing sperm development in males. Using proprietary bait stations, ContraPest is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rodent communities. ContraPest is designed, formulated and dispensed to be safe for handlers and non target species such as wildlife, livestock and pets, in a biodegradable product. In contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental contamination and the poisoning of non target animals, pets and children. We believe our non lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is currently no other non lethal fertility control product approved by the Food and Drug Administration FDA , or the Environmental Protection Agency EPA , for the management of rodent populations. We believe ContraPest will establish a new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative environmental effects of rodenticides. For more information visit the SenesTech website at www.senestech.com.
Quote | SenesTech Inc. (NASDAQ:SNES)
Last: | $0.6689 |
---|---|
Change Percent: | -0.62% |
Open: | $0.65 |
Close: | $0.6689 |
High: | $0.696 |
Low: | $0.6136 |
Volume: | 94,405 |
Last Trade Date Time: | 05/15/2024 03:00:00 am |
News | SenesTech Inc. (NASDAQ:SNES)
SenesTech, a rodent fertility control product and service provider, just launched Evolve(TM) Mouse, a contraceptive specifically designed for mice This marks an extension of the company’s hugely successful Evolve product line, ushering its official entry into the mouse contraceptive mark...
2024-05-10 16:57:07 ET SenesTech, Inc. (SNES) Q1 2024 Earnings Conference Call May 09, 2024 05:00 PM ET Company Participants Robert Blum - Investor Relations, Lytham Partners Joel Fruendt - Chief Executive Officer Tom Chesterman - Chief Financial Officer Co...
Message Board Posts | SenesTech Inc. (NASDAQ:SNES)
Subject | By | Source | When |
---|---|---|---|
How is this even trading?? There mcap is | Roadtojourney | investorshub | 11/21/2022 2:52:48 PM |
I knew these shit bags were gong to | PennyPusher786 | investorshub | 11/16/2022 8:31:58 PM |
Ill buy some here premarket 610k o/s whats | stock1ace1 | investorshub | 11/16/2022 1:40:37 PM |
znewcar1: $SNES 35% v52,4M C.1949 f12,2M H.3859 ML.0796 | znewcar1 | investorshangout | 11/15/2022 10:16:27 PM |
Good luck dino!! | eur06 | investorshub | 11/15/2022 9:13:20 PM |
News, Short Squeeze, Breakout and More Instantly...
SenesTech, a rodent fertility control product and service provider, just launched Evolve(TM) Mouse, a contraceptive specifically designed for mice This marks an extension of the company’s hugely successful Evolve product line, ushering its official entry into the mouse contraceptive mark...
SenesTech (NASDAQ: SNES) , the leader in fertility control to manage animal-pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control(R) products, is reporting its financial and operational results for first quarter 2024. Highlights of the report inclu...
SenesTech Announces First Quarter 2024 Financial Results PR Newswire PHOENIX , May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only manufacturer of...